Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Clinical trial NCT04537715 · COMPLETED

Trial details

NCT number: NCT04537715
Sponsor: Epizyme, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

All Malignancies Advanced Malignancies Hematologic Malignancy Solid Tumor Follicular Lymphoma (FL)Non-Hodgkin Lymphoma (NHL)Diffuse Large B-Cell Lymphoma (DLBCL)Epithelioid Sarcoma (ES)Synovial Sarcoma Renal Medullary Carcinoma Mesothelioma Rhabdoid Tumor

Start date: 2020-04-23
Primary completion: 2023-04-03
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.